Evidence map›Paper›PMID 28056870›Full record

ArticleBMC neurology2017

Anti-N-methyl-D-aspartate receptor(NMDAR) antibody encephalitis presents in atypical types and coexists with neuromyelitis optica spectrum disorder or neurosyphilis.

Kaiyu Qin, Wenqing Wu, Yuming Huang, Dongmei Xu, Lei Zhang, Bowen Zheng, Meijuan Jiang, Cheng Kou, Junhua Gao, Wurong Li and 6 more

Open access · goldAbstract readCase Reports
In one paragraph

Article in BMC neurology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 2 pooled it
6.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 2 syntheses or guidelines pooled it, 77 citations in OpenAlex.

  1. The spectrum of movement disorders in neurosyphilis: A systematic review.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026
    Pooled it
  2. Clinical Characteristics of Anti-Frontiers in immunology · 2022
    Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Observational
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 2 institutions in 1 country.

Kaiyu QinDepartment of neurology, Beijing Ditan Hospital, Capital Medical University, No.8 East Jing Shun Rd, Chaoyang District, Beijing, China.
Wenqing WuDepartment of neurology, Beijing Ditan Hospital, Capital Medical University, No.8 East Jing Shun Rd, Chaoyang District, Beijing, China. ruiyang56@aliyun.com.
Yuming HuangDepartment of neurology, Beijing Ditan Hospital, Capital Medical University, No.8 East Jing Shun Rd, Chaoyang District, Beijing, China.
Dongmei XuDepartment of neurology, Beijing Ditan Hospital, Capital Medical University, No.8 East Jing Shun Rd, Chaoyang District, Beijing, China.
Lei ZhangDepartment of neurology, Beijing Ditan Hospital, Capital Medical University, No.8 East Jing Shun Rd, Chaoyang District, Beijing, China.
Bowen ZhengDepartment of neurology, Beijing Ditan Hospital, Capital Medical University, No.8 East Jing Shun Rd, Chaoyang District, Beijing, China.
Meijuan JiangDepartment of neurology, Beijing Ditan Hospital, Capital Medical University, No.8 East Jing Shun Rd, Chaoyang District, Beijing, China.
Cheng KouDepartment of neurology, Beijing Ditan Hospital, Capital Medical University, No.8 East Jing Shun Rd, Chaoyang District, Beijing, China.
Junhua GaoDepartment of neurology, Beijing Ditan Hospital, Capital Medical University, No.8 East Jing Shun Rd, Chaoyang District, Beijing, China.
Wurong LiDepartment of neurology, Beijing Ditan Hospital, Capital Medical University, No.8 East Jing Shun Rd, Chaoyang District, Beijing, China.
Jinglin ZhangDepartment of neurology, Beijing Ditan Hospital, Capital Medical University, No.8 East Jing Shun Rd, Chaoyang District, Beijing, China.
Sumei WangDepartment of neurology, Beijing Ditan Hospital, Capital Medical University, No.8 East Jing Shun Rd, Chaoyang District, Beijing, China.
Yanfei LuanDepartment of neurology, Beijing Ditan Hospital, Capital Medical University, No.8 East Jing Shun Rd, Chaoyang District, Beijing, China.
Chaoling YanDepartment of neurology, Beijing Ditan Hospital, Capital Medical University, No.8 East Jing Shun Rd, Chaoyang District, Beijing, China.
Dan XuDepartment of neurology, Beijing Ditan Hospital, Capital Medical University, No.8 East Jing Shun Rd, Chaoyang District, Beijing, China.
Xinmei ZhengDepartment of neurology, Beijing Ditan Hospital, Capital Medical University, No.8 East Jing Shun Rd, Chaoyang District, Beijing, China.
Beijing Ditan Hospital · CNCapital Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAnti-N-methyl-D-aspartate receptor (NMDAR) encephalitis is a clinically heterogeneous disorder characterized by epileptic seizures, psychosis, dyskinesia, consciousness impairments, and autonomic instability. Symptoms are always various. Sometimes it presents in milder or incomplete forms. We report 4 cases of anti-NMDAR encephalitis with incomplete forms, 3 cases of which were accompanied by neuromyelitis optica spectrum disorder or neurosyphilis respectively. CASE PRESENTATION: A 33-year-old man presented with dysarthria, movement disorder and occasional seizures. He had 6 relapses in 28 years. When suffered from upper respiratory tract syndrome, he developed behavioral and consciousness impairment. Cranial MRI was normal. Viral PCR studies and oncologic work-up were negative. Anti-NMDAR antibody was detected in CSF and serum. A 21-year-old female manifested dizziness and diplopia ten months and six months before, respectively. Both responded to steroid therapy and improved completely. This time she presented with progressive left limb and facial anesthesia, walking and holding unsteadily. Spinal cord MRI follow-up showed abnormality of medulla oblongata and cervical cord(C1). Anti-AQP4 and anti-NMDAR were positive in CSF. Steroid-pulse therapy ameliorated her symptoms. A 37-year-old male experienced worsening vision. He was confirmed neurosyphilis since the CSF tests for syphilis were positive. Protein was elevated and the oligoclonal IgG bands(OB) and anti-NMDAR was positive in CSF. Anti-aquaporin 4(AQP4) antibodies and NMO-IgG were negative. Cranial MRI showed high FLAIR signal on frontal lobe and low T2 signal adjacent to the right cornu posterious ventriculi lateralis. Treatment for neurosyphlis was commenced with gradual improvement. A 39-year-old male, developed serious behavioral and psychiatric symptoms. Examination showed abnormal pupils and unsteady gait. He was confirmed neurosyphilis according to the CSF tests for syphilis. Anti-NMDAR was positive in CSF and serum. Cranial MRI showed lateral ventricles and the third ventricle enlargement and signal abnormality involving bilateral temporal lobe, corona radiate and centrum semiovale. PenicillinG, pulsed methylprednisolone and intravenous immunoglobulin was administered. He was stable.

conclusionAnti-NMDAR encephalitis can present in atypical types. When relapsing, it may present with partial aspects or with isolated symptoms of the full-blown syndrome. Anti-NMDAR encephalitis may be related to neuromyelitis optica spectrum disorder or neurosyphilis.

Indexed as

AdultAnti-N-Methyl-D-Aspartate Receptor EncephalitisFemaleHumansMaleNeuromyelitis OpticaNeurosyphilisYoung AdultAnti-N-methyl-D-aspartate receptor(NMDAR)Atypical typesNeuromyelitis optica spectrum disorderNeurosyphilis

Identifiers

PMID28056870
PMCPMC5216582
OpenAlexW2567758517

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.